Roche buys US diagnostics firm Ventana

Swiss pharmaceutical giant Roche is to acquire United States diagnostics firm Ventana for $3.4 billion (SFr3.77 billion).

This content was published on January 22, 2008 - 09:36

Roche and Ventana Medical Systems signed a definitive agreement under which Roche will increase the purchase price in its tender offer from $75 to $89.50 per share.

Ventana's board of directors, which had previously rejected Roche's advances, will recommend that shareholders accept the offer, according to a joint statement from both companies on Tuesday.

In late June 2007, Roche made an unsolicited cash offer to buy all of the Arizona company's common shares outstanding but Ventana resisted the approach, deeming the price "inadequate". The final agreed price represents an increase of 19 per cent on the initial offer.

Headquartered in Basel, Roche is one of the world's largest research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.

This article was automatically imported from our old content management system. If you see any display errors, please let us know:

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?